How much does selumetinib cost in medical insurance? How to reimburse?

Selumetinib is a targeted therapy drug that has been launched in China and is included in the medical insurance system. The following is a detailed analysis of the medical insurance reimbursement policy and patient out-of-pocket expenses for selumetinib.
Selumetinib has currently passed relevant approvals and been included in China's medical insurance directory. This means that patients can purchase this drug through the medical insurance system and enjoy a certain proportion of medical insurance reimbursement. After being included in medical insurance, patients can reduce their out-of-pocket portion when purchasing, but the specific reimbursement ratio will vary according to the policies of different regions and hospitals. Therefore, before using selumetinib, patients are advised to consult the local hospital pharmacy or medical insurance department to understand the specific reimbursement policy and payment details.

The domestic retail price of selumetinib’s original drug is about more than 10,000 yuan. Since the drug has been included in medical insurance, patients can enjoy medical insurance reimbursement. The specific reimbursement ratio usually depends on the medical insurance policy of the patient's region and whether it falls within the scope of medical insurance reimbursement. In different regions, the reimbursement ratio of medical insurance may vary. Generally speaking, patients may need to pay part of the drug price after medical insurance reimburses them. In order to obtain accurate reimbursement information, it is best for patients to consult the pharmacy or medical insurance department of their hospital in advance.

In addition to original drugs, patients can also choose imported generic drugs. The price of the generic version produced abroad, especially in Laos, is significantly lower than the original drug, about 2,000 yuan. Although the price is lower, generic drugs are basically the same as the original drugs in terms of drug ingredients and effects, so they are a relatively economical choice. Patients can choose whether to use generic drugs based on their personal financial situation and treatment needs. However, since generic drugs have not yet been included in the domestic medical insurance system, patients still need to pay in full out-of-pocket when purchasing generic drugs.
Even if selumetinib is included in medical insurance, patients' out-of-pocket costs may still be high, especially for patients without medical insurance reimbursement or with a low reimbursement rate. For patients with greater financial pressure, choosing overseas generic drugs may be a relatively affordable option, but they need to pay attention to the formality of their purchasing channels and the quality of the drugs. In any case, patients should fully communicate with their doctors before using selumetinib to understand how the drug is used, possible side effects, and cost issues, so as to make the most suitable treatment decision for them.
Reference: https://www.koselugo.com